Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
36 results:

  • 1. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
    Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
    Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
    Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
    J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly.
    Zhang CY; Zhang R; Zhang L; Wang ZM; Sun HZ; Cui ZG; Zheng HC
    World J Gastroenterol; 2023 Sep; 29(35):5104-5124. PubMed ID: 37744296
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combination of the Ratio Between Negative and Harvested Lymph Nodes and Metastatic Lymph Node Count as a Prognostic Indicator in Stage III Colon cancer: A Retrospective Cohort Study.
    Benli S; Tazeoğlu D; Çolak T
    Am Surg; 2024 Jan; 90(1):38-45. PubMed ID: 37498224
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study.
    Zhang B; Lin Y; Wang C; Chen Z; Huang T; Chen H; Wang G; Lan P; He X; He X
    BMC Cancer; 2023 Jul; 23(1):675. PubMed ID: 37464346
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MRI restaging of rectal cancer: The rac (Response-Anal canal-CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups.
    Nougaret S; Rousset P; Lambregts DMJ; Maas M; Gormly K; Lucidarme O; Brunelle S; Milot L; Arrivé L; Salut C; Pilleul F; Hordonneau C; Baudin G; Soyer P; Brun V; Laurent V; Savoye-Collet C; Petkovska I; Gerard JP; Cotte E; Rouanet P; Catalano O; Denost Q; Tan RB; Frulio N; Hoeffel C
    Diagn Interv Imaging; 2023; 104(7-8):311-322. PubMed ID: 36949002
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lymph node yield in the pathological staging of resected nonmetastatic colon cancer: The more the better?
    Simões P; Fernandes G; Costeira B; Machete M; Baptista C; N Silva D; Leal-Costa L; Prazeres G; Correia J; Albuquerque J; Padrão T; Gomes C; Godinho J; Faria A; Casa-Nova M; Lopes F; Teixeira JA; F Pulido C; Oliveira H; Mascarenhas-Lemos L; Albergaria D; Maio R; Passos-Coelho JL
    Surg Oncol; 2022 Aug; 43():101806. PubMed ID: 35841744
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
    Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
    Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
    Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GPR116 overexpression correlates with poor prognosis in gastric cancer.
    Zheng T; Sun M; Liu L; Lan Y; Wang L; Lin F
    Medicine (Baltimore); 2021 Dec; 100(48):e28059. PubMed ID: 35049225
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast cancer.
    Song Y; Zheng C; Tao Y; Huang R; Zhang Q
    Med Sci Monit; 2021 Aug; 27():e929615. PubMed ID: 34349094
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TRAF5 promotes the occurrence and development of colon cancer via the activation of PI3K/akt/NF-κB signaling pathways.
    Sun G; Zheng C; Deng Z; Huang C; Huang J
    J Biol Regul Homeost Agents; 2020; 34(4):1257-1268. PubMed ID: 32911926
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer.
    Chen X; Wu Y; Gu J; Liang P; Shen M; Xi J; Qin J
    Biofactors; 2020 Jul; 46(4):620-628. PubMed ID: 32078221
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
    Wang Q; Shi YL; Zhou K; Wang LL; Yan ZX; Liu YL; Xu LL; Zhao SW; Chu HL; Shi TT; Ma QH; Bi J
    Cell Death Dis; 2018 Jul; 9(7):739. PubMed ID: 29970892
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prospective evaluation of the performance and interobserver variation in endoscopic ultrasound staging of rectal cancer.
    El Hajj II; DeWitt J; Sherman S; Imperiale TF; LeBlanc JK; McHenry L; Cote GA; Johnson CS; Al-Haddad M
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1013-1018. PubMed ID: 29846267
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
    Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
    Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the akt/GSK-3β Pathway in Gastric cancer.
    Hua K; Li Y; Zhao Q; Fan L; Tan B; Gu J
    Med Sci Monit; 2018 Jan; 24():149-160. PubMed ID: 29306955
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular and Clinicopathological Differences by Age at the Diagnosis of colorectal cancer.
    Chang CC; Lin PC; Lin CC; Lan YT; Lin HH; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK; Lin JK; Chang SC
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678173
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
    Fizazi K; Faivre L; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houede N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Chinet-Charrot P; Legouffe E; Lagrange JL; Linassier C; Deplanque G; Beuzeboc P; Davin JL; Martin AL; Habibian M; Laplanche A; Culine S
    Lancet Oncol; 2015 Jul; 16(7):787-94. PubMed ID: 26028518
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.
    Zhang Q; Tang Q; Qin D; Yu L; Huang R; Lv G; Zou Z; Jiang XC; Zou C; Liu W; Luo J; Zhao Z; Muhammad S; Wang G; Chen YG; Wang X
    Mol Cell Biol; 2015 Mar; 35(6):988-1000. PubMed ID: 25582198
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.